Monte Rosa Therapeutics Inc

$17.76
Market Cap 1.42B
ROE -41.0%
Gross Margin 100.0%
Debt/Equity 0.1
Current Ratio 9.5
Revenue QoQ -95.0%
EPS QoQ -1.8%
F-Score 4

About

Monte Rosa Therapeutics Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-11.22
vs median 35.63
P/B
2.80
vs median 2.25
ROE
-0.41
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

TYRAIMCRNVAXURGNCAPRNTLA
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics